caffeine and raclopride

caffeine has been researched along with raclopride in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Fredholm, BB; Nomikos, GG; Svenningsson, P1
Fredholm, BB; Svenningsson, P1
Aalto, S; Kaasinen, V; NĂ¥gren, K; Rinne, JO2
Alexoff, D; Casado, V; Ferre, S; Fowler, JS; Logan, J; Thanos, PK; Tomasi, D; Volkow, ND; Wang, GJ; Wong, C1

Other Studies

7 other study(ies) available for caffeine and raclopride

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1995, Volume: 15, Issue:11

    Topics: Animals; Caffeine; Corpus Striatum; DNA-Binding Proteins; Dopamine Agonists; Dopamine Antagonists; Drug Combinations; Early Growth Response Protein 1; Ergolines; Gene Expression; Immediate-Early Proteins; In Situ Hybridization; Injections; Male; Motor Activity; Nuclear Receptor Subfamily 4, Group A, Member 1; Proto-Oncogene Proteins c-jun; Quinpirole; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; RNA, Messenger; Salicylamides; Time Factors; Transcription Factors

1995
Caffeine mimics the effect of a dopamine D2/3 receptor agonist on the expression of immediate early genes in globus pallidus.
    Neuropharmacology, 1997, Volume: 36, Issue:9

    Topics: Animals; Autoradiography; Caffeine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Gene Expression; Genes, fos; Genes, Immediate-Early; Genes, jun; Globus Pallidus; In Situ Hybridization; Male; Quinpirole; Raclopride; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Salicylamides

1997
Dopaminergic effects of caffeine in the human striatum and thalamus.
    Neuroreport, 2004, Feb-09, Volume: 15, Issue:2

    Topics: Adult; Arousal; Binding Sites; Binding, Competitive; Brain Mapping; Caffeine; Corpus Striatum; Dopamine; Female; Humans; Male; Middle Aged; Putamen; Raclopride; Receptors, Dopamine D2; Synaptic Transmission; Thalamus; Tomography, Emission-Computed

2004
Expectation of caffeine induces dopaminergic responses in humans.
    The European journal of neuroscience, 2004, Volume: 19, Issue:8

    Topics: Adult; Attitude; Brain; Caffeine; Dopamine; Female; Humans; Male; Middle Aged; Placebo Effect; Protein Binding; Raclopride; Tomography, Emission-Computed

2004
Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.
    Translational psychiatry, 2015, Apr-14, Volume: 5

    Topics: Adult; Affect; Arousal; Blood Pressure; Brain; Caffeine; Caudate Nucleus; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Heart Rate; Humans; Male; Middle Aged; Neostriatum; Positron-Emission Tomography; Putamen; Raclopride; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, Dopamine D3; Ventral Striatum

2015